PIXVEPTY Trademark
Trademark Overview
On Wednesday, December 10, 2025, a trademark application was filed for PIXVEPTY with the United States Patent and Trademark Office. The USPTO has given the PIXVEPTY trademark a serial number of 99540792. The federal status of this trademark filing is ABANDONED - EXPRESS AFTER PUB as of Thursday, April 2, 2026. This trademark is owned by Eli Lilly and Company. The PIXVEPTY trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer’s disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Covid-19 disease, Crohn’s disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, hearing loss, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, neurodegenerative diseases and disorders, neurological disorders, obesity, weight management, obstructive sleep apnea, osteoarthritis, pain, Parkinson’s disease, peripheral arterial ...
General Information
| Serial Number | 99540792 |
| Word Mark | PIXVEPTY |
| Filing Date | Wednesday, December 10, 2025 |
| Status | 605 - ABANDONED - EXPRESS AFTER PUB |
| Status Date | Thursday, April 2, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, February 17, 2026 |
Trademark Statements
| Goods and Services | Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer’s disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Covid-19 disease, Crohn’s disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, hearing loss, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, neurodegenerative diseases and disorders, neurological disorders, obesity, weight management, obstructive sleep apnea, osteoarthritis, pain, Parkinson’s disease, peripheral arterial disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 8 - Abandoned |
| Class Status Date | Thursday, April 2, 2026 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Eli Lilly and Company |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Indianapolis, IN 46285
US |
| Party Name | Eli Lilly and Company |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Indianapolis, IN 46285
US |
Trademark Events
| Event Date | Event Description |
| Wednesday, December 10, 2025 | NEW APPLICATION ENTERED |
| Wednesday, December 10, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, December 10, 2025 | APPLICATION FILING RECEIPT MAILED |
| Thursday, January 15, 2026 | ASSIGNED TO EXAMINER |
| Monday, January 26, 2026 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, February 11, 2026 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, February 17, 2026 | PUBLISHED FOR OPPOSITION |
| Tuesday, February 17, 2026 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Wednesday, March 18, 2026 | EXTENSION OF TIME TO OPPOSE RECEIVED |
| Wednesday, April 1, 2026 | TEAS EXPRESS ABANDONMENT RECEIVED |
| Thursday, April 2, 2026 | ABANDONMENT - AFTER PUBLICATION |
| Thursday, April 2, 2026 | ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION |
| Saturday, April 18, 2026 | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED |
